Vitamin B12
- Generic Name
- Vitamin B12
- Brand Names
- Infuvite Pediatric, Mvc-fluoride, Animi-3 With Vitamin D, Dodex, Fortaplex, Irospan 24/6 Kit, Cobex, Natafort, Infuvite, Vitafol-one, Nascobal, Mvi Pediatric, Hematogen, Folbic, Ferralet 90, Foltabs, Concept Ob, Pregvit, Tandem Plus, B-12
- Drug Type
- Small Molecule
- Chemical Formula
- C62H88CoN13O14P
- CAS Number
- 13408-78-1
- Unique Ingredient Identifier
- 8406EY2OQA
- Background
Cyanocobalamin (commonly known as Vitamin B12) is a highly complex, essential vitamin, owing its name to the fact that it contains the mineral, cobalt. This vitamin is produced naturally by bacteria , and is necessary for DNA synthesis and cellular energy production. Vitamin B12 has many forms, including the cyano-, methyl-, deoxyadenosyl- and hydroxy-cobala...
- Indication
Nasal spray
The cyanocobalamin nasal spray is indicated for the maintenance of vitamin B12 concentrations after normalization with intramuscular vitamin B12 therapy in patients with deficiency of this vitamin who have no nervous system involvement .
...
- Associated Conditions
- Neuritis, Vitamin Deficiency, Vitamin B6 Deficiency, Diabetic Neuropathies, Vitamin B1 deficiency, Anemia, Pernicious, Vitamin B12 Deficiency, Convalescence, Iron Deficiency Anemia (IDA), Folate deficiency, Combined Vitamin B1 and B12 deficiency, Vitamin B12 concentration, Anemia
- Associated Therapies
- Vitamin supplementation, Nutritional supplementation
BVAIT: B-Vitamin Atherosclerosis Intervention Trial
- Conditions
- First Posted Date
- 2005-06-15
- Last Posted Date
- 2009-12-11
- Lead Sponsor
- National Institute on Aging (NIA)
- Target Recruit Count
- 506
- Registration Number
- NCT00114400
- Locations
- 🇺🇸
Atherosclerosis Research Unit, Division of Cardiovascular Medicine, Department of Medicine, Los Angeles, California, United States
VITAL - VITamins to Slow ALzheimer's Disease (Homocysteine Study)
- Conditions
- First Posted Date
- 2003-03-10
- Last Posted Date
- 2009-06-12
- Lead Sponsor
- National Institute on Aging (NIA)
- Target Recruit Count
- 340
- Registration Number
- NCT00056225
- Locations
- 🇺🇸
Georgetown University, Washington, DC, District of Columbia, United States
🇺🇸Mayo Clinic, Scottsdale, Scottsdale, Arizona, United States
🇺🇸Southern Illinois University, Springfield, Illinois, United States
Vitamin Therapy for Prevention of Stroke
- Conditions
- Locations
- 🇺🇸
Wake Forest University School of Medicine, Winston Salem, North Carolina, United States
Randomized Study of Folic Acid Therapy for Hyperhomocysteinemia in Patients With End Stage Renal Disease Receiving Hemodialysis
- Conditions
- First Posted Date
- 1999-10-19
- Last Posted Date
- 2015-03-25
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 84
- Registration Number
- NCT00004495
- Locations
- 🇺🇸
Georgetown University Medical Center, Washington, District of Columbia, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.